Catheter Precision, Inc. (VTAK)

Market Cap	2.70M -13.4%
Revenue (ttm)	730,000 +83.0%
Net Income	-22.19M
EPS	-28.39
Shares Out	1.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,274
Open	1.600
Previous Close	1.590
Day's Range	1.510 - 1.620
52-Week Range	1.140 - 15.681
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2025

About VTAK

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 30, 2018
• Employees: 22
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: VTAK
• Website: https://www.catheterprecision.com

Financial Performance

In 2024, Catheter Precision's revenue was $420,000, a decrease of -4.98% compared to the previous year's $442,000. Losses were -$21.80 million, -69.45% less than in 2023.